Chrome Extension
WeChat Mini Program
Use on ChatGLM

Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database.

Expert review of clinical pharmacology(2022)

Cited 4|Views6
No score
Abstract
Trastuzumab emtansine, trastuzumab deruxtecan and trastuzumab duocarmazine increased the risk of ILD, which can lead to serious outcomes and tends to occur early.
More
Translated text
Key words
Anti-HER2 ADC,Interstitial lung disease,pneumonitis,trastuzumab deruxtecan,trastuzumab emtansine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined